Pharmacokinetics (PK) of Dalfampridine-ER 7.5 mg BID in Healthy Volunteers and Subjects With Mild or Moderate Renal Impairment
Condition(s):Renal InsufficiencyLast Updated:November 7, 2012Completed
Hide Studies Not Open or Pending
Condition(s):Renal InsufficiencyLast Updated:November 7, 2012Completed
Condition(s):Multiple SclerosisLast Updated:October 14, 2013Completed
Condition(s):Multiple SclerosisLast Updated:October 31, 2018Completed
Condition(s):Post-ischemic StrokeLast Updated:January 22, 2019Terminated
Condition(s):Cerebral Palsy (CP)Last Updated:June 24, 2014Completed
Condition(s):Multiple SclerosisLast Updated:November 10, 2015Completed
Condition(s):Ischemic StrokeLast Updated:January 22, 2016Completed
Condition(s):Multiple SclerosisLast Updated:September 5, 2013Completed
Condition(s):Post-Ischemic StrokeLast Updated:June 7, 2018Completed
Condition(s):Spinal Muscular AtrophyLast Updated:May 18, 2016Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.